FREEMAN, MD, Joshua. FDA approves Alzheimer’s drug against the recommendation of its scientific panel. Be very concerned. RRNMF Neuromuscular Journal, [S. l.], v. 2, n. 5, p. 5–6, 2021. DOI: 10.17161/rrnmf.v2i5.15979. Disponível em: https://journals.ku.edu/rrnmf/article/view/15979. Acesso em: 13 apr. 2025.